KDM5A was further identified as a critical factor characterizing drug tolerant persister cancer cells that mediated intrinsic resistance towards chemotherapy in a non-small cell lung cancer (SCLC) cell line (Sharma et al., 2010; Vinogradova et al., 2016). This evidence concerns the gene KDM5A and small cell lung carcinoma.